The survey also showed that 53 percent of adults 18 through 64 years of age who were vaccinated annually reported that their vaccination experience would be better if the needle was much smaller, and 65 percent said their experience would be better if access to the flu shot was more convenient.
A local survey of 400 adults in Baltimore revealed similar results as three out of every four (75 percent) adults 18 through 64 years of age said if they had influenza, they fear spreading the virus to their loved ones, yet over half (54 percent) of adults said they are not vaccinated annually.
Flu clinic attendees will have the opportunity to have one-on-one discussions with a Rite Aid pharmacist to better understand the importance of annual influenza vaccination, how to help protect themselves and their loved ones, and the various vaccine options that are available for adults 18 through 64 years of age this flu season. Rite Aid pharmacists will also be able to administer the Fluzone Intradermal vaccine. Age and health-related restrictions may apply.
The Coop de Quill vehicle, which features a supersized rooftop 3D structure of the Fluzone Intradermal vaccine, will be on-site for attendees to interact with.For adults unable to attend the flu clinic event on Friday, immunization options, including Fluzone Intradermal vaccine, are available at Rite Aid pharmacies in Baltimore throughout the season. To locate the nearest Rite Aid pharmacy, visit www.riteaid.com or call 1-800-RITE-AID. Fluzone Intradermal vaccine is the only FDA-approved intradermal flu vaccine for adults 18 through 64 years of age in the United States. The device features an ultra-thin, 90 percent smaller needle that works just under the skin to help provide adults with the flu protection they need. To find out where Fluzone Intradermal vaccine is available in your area, or to learn more about Fluzone Intradermal vaccine, visit www.Fluzone.com. Prior to Baltimore, the Coop de Quill vehicle made stops in four tour cities: Chicago, Seattle, San Francisco, and Raleigh throughout the flu season. About Fluzone Intradermal Vaccine Coop de Quill VacciNation Tour The Fluzone Intradermal Vaccine Coop de Quill VacciNation Tour is a national initiative that aims to raise awareness about the seriousness of influenza and the various vaccine options that are available for adults this flu season. Sanofi Pasteur and Actor Chris O'Donnell are teaming up to educate adults, a sometimes overlooked population, that the single most important thing they can do to help prevent getting or spreading the flu is to get their annual vaccination. Chris will share his personal flu vaccination experience and help to educate about this potentially deadly disease and vaccine options through various media activities this flu season. Additionally, the Coop de Quill VacciNation Tour is joining forces with various retailers, including Walgreens, CVS and Rite Aid, to bring Fluzone Intradermal vaccine to cities across the nation. The Coop de Quill vehicle will be making a stop in five tour cities: Baltimore, Chicago, Raleigh, San Francisco, and Seattle. At each stop attendees will have the opportunity to have one-on-one discussions with clinic pharmacists to better understand the importance of annual influenza vaccination and the various vaccine options available to them. Attendees can also get immunized with Fluzone Intradermal vaccine. The Fluzone Intradermal Vaccine Coop de Quill VacciNation Tour is a program of Sanofi Pasteur, makers of Fluzone Intradermal vaccine. About Influenza Influenza is a serious respiratory illness that is easily spread and can lead to severe complications, even death. Each year in the U.S., 1 in 5 people, or up to 20 percent of the population gets the flu, and on average, influenza and its related complications result in approximately 226,000 hospitalizations. Influenza seasons are unpredictable and can be severe. Depending on virus severity during the influenza season, annual deaths can range from a low of 3,000 to a high of about 49,000 people. Combined with pneumonia, influenza is the nation's ninth leading cause of death. Vaccination is safe and effective and the best way to help prevent influenza and its complications.